Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.

Ginseng extracts show cognition-enhancing effects in Alzheimer's disease (AD) patients. However, little is known about the active components and molecular mechanisms of how ginseng exerts its effects. Recently, we isolated a novel lysophosphatidic acid (LPA) receptor-activating ligand from ginseng, gintonin. AD is caused by amyloid-β protein (Aβ) accumulation. Aβ is derived from amyloid-β protein precursors (AβPPs) through the amyloidogenic pathway. In contrast, non-amyloidogenic pathways produce beneficial, soluble AβPPα (sAβPPα). Here, we describe our investigations of the effect of gintonin on sAβPPα release, Aβ formation, Swedish-AβPP transfection-mediated neurotoxicity in SH-SY5Y neuroblastoma cells, and Aβ-induced neuropathy in mice. Gintonin promoted sAβPPα release in a concentration- and time-dependent manner. Gintonin action was also blocked by the Ca2+ chelator BAPTA, α-secretase inhibitor TAPI-2, and protein-trafficking inhibitor brefeldin. Gintonin decreased Aβ1-42 release and attenuated Aβ1-40-induced cytotoxicity in SH-SY5Y cells. Gintonin also rescued Aβ1-40-induced cognitive dysfunction in mice. Moreover, in a transgenic mouse AD model, long-term oral administration of gintonin attenuated amyloid plaque deposition as well as short- and long-term memory impairment. In the present study, we demonstrated that gintonin mediated the promotion of non-amyloidogenic processing to stimulate sAβPPα release to restore brain function in mice with AD. Gintonin could be a useful agent for AD prevention or therapy.

[1]  Y. Suh,et al.  Swedish amyloid precursor protein mutation increases phosphorylation of eIF2α in vitro and in vivo , 2007, Journal of neuroscience research.

[2]  H. Braak,et al.  Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: A third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques , 1986, Neuroscience Letters.

[3]  B. Strooper,et al.  The role of G protein-coupled receptors in the pathology of Alzheimer's disease , 2011, Nature Reviews Neuroscience.

[4]  Patrick L. McGeer,et al.  Inflammatory processes in Alzheimer's disease , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  D. Small,et al.  The role of Abeta-induced calcium dysregulation in the pathogenesis of Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[6]  Ho-Chul Shin,et al.  Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity , 2012, Molecules and cells.

[7]  D. Seals,et al.  The ADAMs family of metalloproteases: multidomain proteins with multiple functions. , 2003, Genes & development.

[8]  K. Fukunaga,et al.  Activation of phosphatidylinositol 3-kinase/protein kinase B pathway by a vanadyl compound mediates its neuroprotective effect in mouse brain ischemia , 2007, Neuroscience.

[9]  J. Belknap,et al.  Intracerebroventricular injections in mice. Some methodological refinements. , 1986, Journal of pharmacological methods.

[10]  J. Growdon,et al.  Activation of protein kinase C inhibits cellular production of the amyloid beta-protein. , 1993, The Journal of biological chemistry.

[11]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[12]  Byung-Hwan Lee,et al.  A Simple Method for the Preparation of Crude Gintonin from Ginseng Root, Stem, and Leaf , 2011, Journal of ginseng research.

[13]  J. Camden,et al.  P2Y2 Nucleotide Receptors Enhance α-Secretase-dependent Amyloid Precursor Protein Processing* , 2005, Journal of Biological Chemistry.

[14]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[15]  F. LaFerla,et al.  M1 agonists as a potential disease-modifying therapy for Alzheimer's disease. , 2009, Current Alzheimer research.

[16]  R. Hughes.  The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory , 2004, Neuroscience & Biobehavioral Reviews.

[17]  José María Delgado-García,et al.  Associative Learning and CA3–CA1 Synaptic Plasticity Are Impaired in D1R Null, Drd1a−/− Mice and in Hippocampal siRNA Silenced Drd1a Mice , 2010, The Journal of Neuroscience.

[18]  T. Nabeshima,et al.  Effects of a Novel Cognitive Enhancer, Spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on Learning Impairments Induced by Amyloid-β1–40 in the Rat , 2006, Journal of Pharmacology and Experimental Therapeutics.

[19]  H. Tanila,et al.  Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD) , 2007, Neurobiology of Disease.

[20]  T. Nabeshima,et al.  β-Amyloid (1–42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex , 2004, Behavioural Brain Research.

[21]  D. Olton,et al.  Age-related spatial reference and working memory deficits assessed in the water maze , 1995, Neurobiology of Aging.

[22]  E. Kojro,et al.  Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Hong-Qi Yang,et al.  New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing α‐secretase activity , 2007, The European journal of neuroscience.

[24]  B. Yankner.  Mechanisms of Neuronal Degeneration in Alzheimer's Disease , 1996, Neuron.

[25]  R. Wurtman,et al.  Elevated intracellular calcium concentration increases secretory processing of the amyloid precursor protein by a tyrosine phosphorylation-dependent mechanism. , 1996, The Biochemical journal.

[26]  P. Greengard,et al.  Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Bernd Giese,et al.  Targeting phosphoinositide 3-kinase: moving towards therapy. , 2008, Biochimica et biophysica acta.

[28]  K. Chu,et al.  An open‐label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer’s disease , 2008, European journal of neurology.

[29]  Steffen Roßner,et al.  The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling , 1998, Progress in Neurobiology.

[30]  Soon-Tae Lee,et al.  Panax Ginseng Enhances Cognitive Performance in Alzheimer Disease , 2008, Alzheimer disease and associated disorders.

[31]  W. M. van der Flier,et al.  Cognitive decline in AD and mild cognitive impairment is associated with global brain damage , 2002, Neurology.

[32]  Sarah Spiegel,et al.  International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature , 2010, Pharmacological Reviews.

[33]  Hwa‐Jung Kim,et al.  Capacitative Ca2+ entry is involved in regulating soluble amyloid precursor protein (sAPPα) release mediated by muscarinic acetylcholine receptor activation in neuroblastoma SH‐SY5Y cells , 2006, Journal of neurochemistry.

[34]  S. Nah,et al.  Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration , 2010, Neurochemistry International.

[35]  P. Maycox,et al.  Lysophosphatidic Acid-induced Ca2+ Mobilization Requires Intracellular Sphingosine 1-Phosphate Production , 2000, The Journal of Biological Chemistry.

[36]  Carolyn A. Coughlan,et al.  Effects of donepezil on amyloid-β and synapse density in the Tg2576 mouse model of Alzheimer's disease , 2009, Brain Research.

[37]  E. Kojro,et al.  The neuropeptide PACAP promotes ?‐secretase pathway for processing Alzheimer amyloid precursor protein , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  W. Moolenaar.  LPA: a novel lipid mediator with diverse biological actions. , 1994, Trends in cell biology.

[39]  B. Szabó,et al.  Putative function of ADAM9, ADAM10, and ADAM17 as APP -secretase , 2003 .

[40]  R. Schliebs,et al.  Induction of cytokines in glial cells surrounding cortical β-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology , 2000, International Journal of Developmental Neuroscience.

[41]  F. Fahrenholz.  Alpha-secretase as a therapeutic target. , 2007 .

[42]  A. Alzheimer.  Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .